Pentasa foam (mesalazine foam)
/ Ferring, Takeda
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 16, 2025
Diagnostic Challenges of Upper Gastrointestinal Tract Crohn's Disease.
(PubMed, Cureus)
- "Despite multiple normal findings on various endoscopic and imaging evaluations, his symptoms persisted, leading to numerous treatment modifications from Pentasa foam enema to various biologics. This case underscores the diagnostic challenges of upper GIT CD and highlights the importance of thorough endoscopic and histological evaluations for accurate diagnosis and effective management. Additionally, it underscores the usefulness of fecal calprotectin as an indication of inflammation and the relevance of nutritional management in controlling symptoms of upper GIT CD."
Journal • Crohn's disease • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease
August 07, 2014
Shire, AstraZeneca fall as U.S. looks to deter inversions
(Bloomberg.com)
- "Drugmakers Shire Plc (SHP) and AstraZeneca Plc (AZN) fell in New York trading after the Obama administration said it would seek to deter U.S. companies from buying foreign competitors to avoid domestic taxes."
Anticipated M & A • Stock price • Ankylosing Spondylitis • Biosimilar • Inflammatory Bowel Disease • Psoriasis • Rheumatoid Arthritis
1 to 2
Of
2
Go to page
1